Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Retinoblastoma × Lasers × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Warts 2 Neurofibromatosis 1 2 Breast Neoplasms 2 Stomatitis 1 Retinoblastoma 1 Retinal Neoplasms 1 Prostatic Neoplasms 1 Port-Wine Stain 1 Pancreatic Neoplasms 1 Osteoma, Osteoid 1 Nevus of Ota 1 Neurofibromatoses 1 Neoplasms 1 Mucositis 1 Lymphedema 1 Keratosis, Actinic 1 Hemangioma, Capillary 1 Cholangiocarcinoma 1 Bile Duct Neoplasms 1 Atrophy 1

Interventions

Carboplatin 23 Etoposide 19 Vincristine 16 Melphalan 13 Filgrastim 13 Topotecan 10 Granulocyte Colony-Stimulating Factor 9 Cyclophosphamide 8 Thiotepa 7 Cryotherapy 7 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Drug Therapy 4 Doxorubicin 3 Busulfan 3 Brachytherapy 3 Temozolomide 2 Radiotherapy 2 Platinum Compounds 2 Magnetic Resonance Imaging 2 Ifosfamide 2 Eye Enucleation 2 Cisplatin 2 Blood Specimen Collection 2 trioctyl phosphine oxide 1 sargramostim 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡